Budapest Open Access Initiative      

Budapest Open Access Initiative: BOAI Forum Archive

[BOAI] [Forum Home] [index] [prev] [next] [options] [help]

boaiforum messages

[BOAI] Fwd: Bioscientifica broadens open access licence options

From: Peter Suber <peter.suber AT gmail.com>
Date: Fri, 15 Mar 2013 13:31:48 -0400


--e89a8f83aa33f6dfeb04d7fa055c
Content-Type: text/plain; charset=windows-1252
Content-Transfer-Encoding: quoted-printable

[Forwarding from Paul MacKenzie-Cummins at Bioscientifica, the commercial
subsidiary of the Society for Endocrinology.  --Peter Suber.]


*Bioscientifica broadens open access licence options*

*BRISTOL, MARCH 15 2013* - Bioscientifica are pleased to announce that our
journals will now be moving to a CC-BY (Creative Commons Attribution) licen=
ce,
with immediate effect. This change of policy will affect all research
published on an open access basis and means that we will be relinquishing
rights over the commercial reuse of accepted articles.  This policy is in
line with the new funding requirements from the Wellcome Trust and Research
Councils UK, which come into force from April 2013.  This new initiative
covers the following Bioscientifica published journals:

**=B7         ***Endocrine-Related Cancer<http://erc.endocrinology-journals=
.org/>
*

**=B7         ***European Journal of Endocrinology<http://www.eje-online.or=
g/>
*

**=B7         ***Journal of Endocrinology<http://joe.endocrinology-journals=
.org/>
*

**=B7         ***Journal of Molecular
Endocrinology<http://jme.endocrinology-journals.org/>
*

**=B7         ***Reproduction <http://www.reproduction-online.org/>*

*Endocrine Connections <http://www.endocrineconnections.com/>*, our fully
open access journal, already conforms to CC-BY standards.

Kathryn Spiller, Head of Publishing at Bioscientifica, said: =93*Bioscienti=
fica
is excited to introduce this new initiative which will allow us to achieve
sustainable open access and allow the broader access to our journals. This
change is aimed at supporting the scientific community in disseminating
their research findings as well as complying with funders=92 requirements.*=
=94

We will continue to offer subscribing institutions a half price article
processing charge (APC) for all our journals.

*Note to Editors*

*About Bioscientifica*

Bioscientifica offers a range of publication services including publishing
journals, books and newsletters, events management, membership services,
website design and maintenance. They are the wholly owned commercial
subsidiary of the Society for Endocrinology. For further information visit:
*http://www.bioscientifica.com/*

*Media contact*

For further information, please contact:****

Paul MacKenzie-Cummins, Communications & PR Manager, Bioscientifica****

Tel: +(0)1454 642 772, Email: paul.mackenzie-cummins AT bioscientifica.com****

**

--e89a8f83aa33f6dfeb04d7fa055c
Content-Type: text/html; charset=windows-1252
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr"><div class=3D"gmail_default" 
style=3D"font-family:&#39;tre=
buchet ms&#39;,sans-serif;font-size:small">[Forwarding from Paul 
MacKenzie-=
Cummins at Bioscientifica, the commercial subsidiary of the Society for End=
ocrinology.=A0 --Peter Suber.]</div>

<br><div class=3D"gmail_quote"><br><div 
lang=3D"EN-GB" link=3D"blue" vlink=
=3D"purple"><p class=3D"" align=3D"center" 
style=3D"text-align:center;line-=
height:17pt"><b><span 
style=3D"font-size:14pt;font-family:Arial,sans-serif"=
>Bioscientifica broadens open access licence 
options</span></b></p>

<p class=3D"" 
style=3D"text-align:justify;line-height:17pt"><b><span 
style=
=3D"font-size:10pt;font-family:Arial,sans-serif">BRISTOL, MARCH 15 
2013</sp=
an></b><span 
style=3D"font-size:10pt;font-family:Arial,sans-serif"> - Biosc=
ientifica are pleased to announce that our journals will now be moving to a=
 CC-BY (</span><span lang=3D"EN" 
style=3D"font-size:10pt;font-family:Arial,=
sans-serif">Creative Commons Attribution)</span><span 
lang=3D"EN" style=3D"=
font-size:10pt;font-family:Arial,sans-serif"> </span><span 
style=3D"font-si=
ze:10pt;font-family:Arial,sans-serif">licence, with immediate effect. 
This =
change of policy will affect all research published on an open access basis=
 and means that we will be relinquishing rights over the commercial reuse o=
f accepted articles.=A0 This policy is in line with the new funding require=
ments from the Wellcome Trust and Research Councils UK, which come into for=
ce from April 2013.=A0 This new initiative covers the following Bioscientif=
ica published journals:</span></p>

<p 
style=3D"margin-bottom:0.0001pt;line-height:17pt"><u></u><span style=3D"=
font-size:10pt;font-family:Symbol"><span>=B7<span 
style=3D"font-style:norma=
l;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;f=
ont-family:&#39;Times New Roman&#39;">=A0=A0=A0=A0=A0=A0=A0=A0 
</span></spa=
n></span><u></u><b><i><u><span 
style=3D"font-size:10pt;font-family:Arial,sa=
ns-serif"><a 
href=3D"http://erc.endocrinology-journals.org/" target=3D"_bla=
nk"><span style=3D"color:windowtext">Endocrine-Related 
Cancer</span></a><u>=
</u><u></u></span></u></i></b></p>

<p 
style=3D"margin-bottom:0.0001pt;line-height:17pt"><u></u><span style=3D"=
font-size:10pt;font-family:Symbol"><span>=B7<span 
style=3D"font-style:norma=
l;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;f=
ont-family:&#39;Times New Roman&#39;">=A0=A0=A0=A0=A0=A0=A0=A0 
</span></spa=
n></span><u></u><b><i><u><span 
style=3D"font-size:10pt;font-family:Arial,sa=
ns-serif"><a href=3D"http://www.eje-online.org/" 
target=3D"_blank"><span st=
yle=3D"color:windowtext">European Journal of 
Endocrinology</span></a><u></u=
><u></u></span></u></i></b></p>

<p 
style=3D"margin-bottom:0.0001pt;line-height:17pt"><u></u><span style=3D"=
font-size:10pt;font-family:Symbol"><span>=B7<span 
style=3D"font-style:norma=
l;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;f=
ont-family:&#39;Times New Roman&#39;">=A0=A0=A0=A0=A0=A0=A0=A0 
</span></spa=
n></span><u></u><b><i><u><span 
style=3D"font-size:10pt;font-family:Arial,sa=
ns-serif"><a 
href=3D"http://joe.endocrinology-journals.org/" target=3D"_bla=
nk"><span style=3D"color:windowtext">Journal of 
Endocrinology</span></a><u>=
</u><u></u></span></u></i></b></p>

<p 
style=3D"margin-bottom:0.0001pt;line-height:17pt"><u></u><span style=3D"=
font-size:10pt;font-family:Symbol"><span>=B7<span 
style=3D"font-style:norma=
l;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;f=
ont-family:&#39;Times New Roman&#39;">=A0=A0=A0=A0=A0=A0=A0=A0 
</span></spa=
n></span><u></u><b><i><u><span 
style=3D"font-size:10pt;font-family:Arial,sa=
ns-serif"><a 
href=3D"http://jme.endocrinology-journals.org/" target=3D"_bla=
nk"><span style=3D"color:windowtext">Journal of 
Molecular Endocrinology</sp=
an></a><u></u><u></u></span></u></i></b></p>

<p 
style=3D"margin-bottom:0.0001pt;line-height:17pt"><u></u><span style=3D"=
font-size:10pt;font-family:Symbol"><span>=B7<span 
style=3D"font-style:norma=
l;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;f=
ont-family:&#39;Times New Roman&#39;">=A0=A0=A0=A0=A0=A0=A0=A0 
</span></spa=
n></span><u></u><b><i><u><span 
style=3D"font-size:10pt;font-family:Arial,sa=
ns-serif"><span style=3D"color:windowtext"><a 
href=3D"http://www.reproducti=
on-online.org/" 
target=3D"_blank">Reproduction</a></span></span></u></i></b=
></p>

<p class=3D"" 
style=3D"text-align:justify;line-height:17pt"><b><i><u><span =
style=3D"font-size:10pt;font-family:Arial,sans-serif"><a 
href=3D"http://www=
.endocrineconnections.com/" target=3D"_blank"><span 
style=3D"font-family:Ca=
libri,sans-serif;color:windowtext">Endocrine 
Connections</span></a></span><=
/u></i></b><span 
style=3D"font-size:10pt;font-family:Arial,sans-serif">, ou=
r fully open access journal, already conforms to CC-BY 
standards.</span></p=
>

<p class=3D"" 
style=3D"text-align:justify;line-height:17pt"><span 
style=3D"=
font-size:10pt;font-family:Arial,sans-serif">Kathryn Spiller, Head of 
Publi=
shing at Bioscientifica, said: =93<i>Bioscientifica is excited to 
introduce=
 this new initiative which will allow us to achieve sustainable open access=
 and allow the broader access to our journals. This change is aimed at supp=
orting the scientific community in disseminating their research findings as=
 well as complying with funders=92 
requirements.</i>=94</span></p>

<p class=3D"" 
style=3D"text-align:justify;line-height:17pt"><span 
style=3D"=
font-size:10pt;font-family:Arial,sans-serif">We will continue to offer 
subs=
cribing institutions a half price article processing charge (APC) for all o=
ur journals.</span></p>

<p class=3D"" 
style=3D"line-height:17pt"><b><span 
style=3D"font-size:10pt;f=
ont-family:Arial,sans-serif">Note to 
Editors</span></b></p><p class=3D"" st=
yle=3D"line-height:17pt"><b><span 
style=3D"font-size:10pt;font-family:Arial=
,sans-serif">About 
Bioscientifica<u></u><u></u></span></b></p>

<p class=3D"" style=3D"line-height:17pt"><span 
style=3D"font-size:10pt;font=
-family:Arial,sans-serif">Bioscientifica offers a range of publication 
serv=
ices including publishing journals, books and newsletters, events managemen=
t, membership services, website design and maintenance. They are the wholly=
 owned commercial subsidiary of the Society for Endocrinology. For further =
information visit: <b><u><span 
style=3D"color:windowtext"><a href=3D"http:/=
/www.bioscientifica.com/" 
target=3D"_blank">http://www.bioscientifica.com/<=
/a></span></u></b></span></p>

<p class=3D"" 
style=3D"line-height:17pt"><b><span 
style=3D"font-size:10pt;f=
ont-family:Arial,sans-serif">Media 
contact<u></u><u></u></span></b></p><p c=
lass=3D"" style=3D"line-height:17pt"><span 
style=3D"font-size:10pt;font-fam=
ily:Arial,sans-serif">For further information, please 
contact:<u></u><u></u=
></span></p>

<p class=3D"" style=3D"line-height:17pt"><span 
style=3D"font-size:10pt;font=
-family:Arial,sans-serif">Paul MacKenzie-Cummins, Communications 
&amp; PR M=
anager, 
Bioscientifica<u></u><u></u></span></p><p class=3D""><span style=3D=
"font-size:10pt;font-family:Arial,sans-serif">Tel: +(0)1454 642 
772, Email:=
 <a href=3D"mailto:paul.mackenzie-cummins AT bioscientifica.com" 
target=3D"_bl=
ank"><span 
style=3D"color:windowtext">paul.mackenzie-cummins AT 
bioscientifica=
.com</span></a></span><u></u><u></u></p>

<p 
class=3D""><u></u>=A0</p></div></div></div>

--e89a8f83aa33f6dfeb04d7fa055c--

        
--      
To unsubscribe from the BOAI Forum, use the form on this page:
http://www.soros.org/openaccess/forum.shtml?f


[BOAI] [Forum Home] [index] [prev] [next] [options] [help]

 E-mail:  openaccess@soros.org .